Sugammadex Ideogen 200 mg / 2 ml
Sugammadex Ideogen 200 mg / 2 ml is a medicine authorised by Swissmedic under authorisation number 68594. The authorisation holder is IDEOGEN AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 November 2023 and the authorisation is limited until 02 November 2028. ATC code V03AB35 places the medicine in the group All other therapeutic products.
| Authorisation number | 68594 |
|---|---|
| Name | Sugammadex Ideogen 200 mg / 2 ml |
| Full name | Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung |
| Authorisation holder | IDEOGEN AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AB35 |
| First authorisation | 03 November 2023 |
| Authorisation validity | 02 November 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung | B | 03 November 2023 |
| 2 | Sugammadex Ideogen 500 mg / 5 ml, Injektionslösung | B | 03 November 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 x 2 ml | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
| 2 | 10 x 5 ml | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sugammadex Ideogen 200 mg / 2 ml authorised in Switzerland?
Yes. Sugammadex Ideogen 200 mg / 2 ml is authorised by Swissmedic under authorisation number 68594, data as of 01 September 2026. The authorisation is limited until 02 November 2028.
Which dispensing category does Sugammadex Ideogen 200 mg / 2 ml have?
Sugammadex Ideogen 200 mg / 2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sugammadex Ideogen 200 mg / 2 ml?
The authorisation holder is IDEOGEN AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.